Search for: "United States v. Articles of Drug"
Results 621 - 640
of 2,501
Sort by Relevance
|
Sort by Date
4 Dec 2019, 11:00 pm
The 1895 decision in Sparf v. [read post]
4 Dec 2019, 6:00 am
New Hampshire has the highest level of outbound smuggling at 65 percent of consumption, likely due to its relatively low tax rates and proximity to high-tax states in the northeastern United States. [read post]
3 Dec 2019, 2:34 pm
Youngs Drug Prods. [read post]
29 Nov 2019, 11:03 am
In United States v. [read post]
13 Nov 2019, 10:35 am
(This article was first published in The Recorder on November 12, 2019.) [read post]
5 Nov 2019, 3:59 am
At Reason (via How Appealing), Damon Root looks at the federal government’s cert petition in United States v. [read post]
27 Oct 2019, 1:00 pm
’s Pat Mador and Alice Clifford, State chemist Heather Dyer, toxicologist Dr. [read post]
18 Oct 2019, 9:00 am
United States v. [read post]
15 Oct 2019, 5:27 pm
The article discloses a study of erlotinib and states that the drug appears to have good anti-cancer activity in preclinical models, particularly in NSCLC patients. [read post]
Case o' The Week: Ninth's Decision is Clear and Convincing -- Valle and Sentencing Standard of Proof
13 Oct 2019, 11:58 am
United States v. [read post]
11 Oct 2019, 9:05 pm
In United States v. [read post]
11 Oct 2019, 10:56 am
(Apotex) challenged OSI’s patent by filing a petition for Inter Partes Review (IPR) at the United States Patent and Trademark Office (USPTO). [read post]
11 Oct 2019, 7:46 am
In United States of America v. [read post]
11 Oct 2019, 1:20 am
United States. [read post]
2 Oct 2019, 10:21 am
Ramos v. [read post]
30 Sep 2019, 2:22 pm
State v. [read post]
30 Sep 2019, 2:22 pm
State v. [read post]
30 Sep 2019, 2:22 pm
State v. [read post]
18 Sep 2019, 2:08 pm
CMS states in the new Final Rule that it will publish further rulemaking to expand this reporting requirement after assessing the progress of its initial phased-in approach. [read post]
18 Sep 2019, 2:08 pm
CMS states in the new Final Rule that it will publish further rulemaking to expand this reporting requirement after assessing the progress of its initial phased-in approach. [read post]
